{"id":1102,"date":"2026-06-01T10:00:00","date_gmt":"2026-06-01T08:00:00","guid":{"rendered":"https:\/\/www.amypore.com\/publications-scienti\/targeting-gangliosides-to-treat-alzheimers-and-parkinsons-diseases-a-disruptive-approach-with-the-first-in-class-peptide-amyp53\/"},"modified":"2026-09-25T14:15:15","modified_gmt":"2026-09-25T12:15:15","slug":"targeting-gangliosides-to-treat-alzheimers-and-parkinsons-diseases-a-disruptive-approach-with-the-first-in-class-peptide-amyp53","status":"publish","type":"publications-scienti","link":"https:\/\/www.amypore.com\/en\/publications-scienti\/targeting-gangliosides-to-treat-alzheimers-and-parkinsons-diseases-a-disruptive-approach-with-the-first-in-class-peptide-amyp53\/","title":{"rendered":"Targeting gangliosides to treat Alzheimer\u2019s and Parkinson\u2019s diseases: A disruptive approach with the first-in-class peptide AmyP53"},"template":"","class_list":["post-1102","publications-scienti","type-publications-scienti","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.amypore.com\/en\/wp-json\/wp\/v2\/publications-scienti\/1102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amypore.com\/en\/wp-json\/wp\/v2\/publications-scienti"}],"about":[{"href":"https:\/\/www.amypore.com\/en\/wp-json\/wp\/v2\/types\/publications-scienti"}],"wp:attachment":[{"href":"https:\/\/www.amypore.com\/en\/wp-json\/wp\/v2\/media?parent=1102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}